Drugs / Oral Metronidazole
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT04046900 Comparator | Apr 2021 → Jan 2027 expected | bacterial vaginosis | Douglas Kwon | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oral Metronidazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04046900 ↗ |
| Known as | metronidazole | “500mg oral metronidazole twice daily for 7 days” NCT04046900 ↗ |
| Route | Oral | “500mg oral metronidazole twice daily for 7 days” NCT04046900 ↗ |